Peptides for Men's Health (2026): What the Evidence and the FDA Say

Peptides are short chains of amino acids that act as signaling molecules in the body, and a handful of them have become popular in men's health circles for recovery, testosterone and sexual function. The marketing is far ahead of the evidence. This guide covers what human research has and has not shown for the most discussed compounds, their regulatory status, and the safety issues that come with unapproved injectable products.

What Are Peptides?

Peptides are chains of amino acids, generally shorter than proteins. The body makes many of them to regulate processes such as appetite, inflammation, sleep and hormone release. Some peptide drugs are approved and well studied. The ones marketed online for performance and longevity mostly are not, and the evidence for them ranges from early human experiments to animal studies only. Most are given by injection, which means product sterility and purity matter a great deal.

Regulatory Status and Safety First

Regulation of peptides in the United States has been shifting. Before looking at individual compounds, it helps to understand the baseline.

• An unapproved drug cannot be legally sold for human use in interstate commerce. In a June 2026 warning letter to an online peptide seller, FDA stated that despite “RESEARCH USE ONLY” and “not for human consumption” labeling, the products were intended to be drugs for human use, and that injectable products can pose risks of serious harm because they bypass some of the body's key defenses against toxins and microorganisms.^[4]
• Some peptides can be made by licensed compounding pharmacies if they are on an FDA list, but the lists are changing and a compounded drug is not an FDA-approved drug.
• Some peptides are banned in competitive sport. Athletes should check their organization's rules.^[5]

BPC-157

BPC-157 is a 15-amino-acid peptide derived from a protein found in human gastric juice. It is promoted online for tendon, gut and muscle healing. A 2025 systematic review of the orthopedic literature found 36 studies, 35 preclinical and 1 clinical. The one clinical study was a retrospective report on knee injections for chronic knee pain in which 7 of 12 patients reported relief for more than 6 months, and the review found no clinical safety data.^[5]

FDA's staff briefing for the July 2026 advisory committee reached a similar conclusion. It found five published clinical studies that used BPC-157 (including rectal, intra-articular, intravesical and intravenous administration in small numbers of people), found no studies giving it by the oral, subcutaneous, nasal or transdermal routes, and described the clinical safety information as insufficient. It also said the immunogenicity risk (the chance of the immune system reacting to the peptide or its impurities) could not be ruled out.^[1]FDA staff proposed not adding BPC-157 to the 503A compounding list, while the advisory committee voted 8 to 6 to recommend adding it. The vote is advisory and non-binding.^[1][2]

Kisspeptin

Kisspeptin is a naturally occurring hypothalamic signal that helps control the release of GnRH, which drives LH, FSH and testosterone production. It is a research tool, not a therapy. In a 2026 randomized, placebo-controlled study from Imperial College London in 15 healthy men, subcutaneous kisspeptin-10 infusions increased LH, FSH and testosterone in a dose-dependent way, and a 12-day schedule of daily 8-hour infusions sustained increases in gonadotropins.^[3] The authors framed the work as helping to develop protocols for treating reproductive disorders in the future. These were small experiments in healthy volunteers using infusions, not self-injected products, and we found no approved kisspeptin treatment for men.

CJC-1295 and Ipamorelin

These are growth hormone secretagogues, meaning they are intended to raise growth hormone (GH), not testosterone. In a 2006 trial in healthy adults aged 21 to 61, single injections of CJC-1295 raised mean GH concentrations 2- to 10-fold for 6 days or more, and IGF-I 1.5- to 3-fold for 9 to 11 days. No serious adverse reactions were reported in that study.^[6] Ipamorelin was tested in a phase 2 randomized trial of 117 patients after bowel surgery, where it was well tolerated but did not significantly speed recovery of the gut compared with placebo.^[7]

We found no randomized trial showing that either compound raises testosterone or benefits men's health outcomes. Growth hormone has wide effects, including on blood sugar, so anyone with diabetes or metabolic problems should discuss this with a doctor.

PT-141 (Bremelanotide)

Bremelanotide (Vyleesi) is a melanocortin receptor agonist that was approved in the United States for premenopausal women with acquired, generalized hypoactive sexual desire disorder.^[8] It is not approved for men, and we did not find reliable trial evidence for its use in male sexual dysfunction. It is also not a testosterone treatment. Men with erectile or desire problems should see a doctor, because approved options exist and these symptoms can signal other conditions.

Enclomiphene (Not a Peptide)

Enclomiphene is sometimes grouped with peptides, but it is a small molecule that blocks estrogen receptors. In two phase III trials in overweight men aged 18 to 60 with secondary hypogonadism, oral enclomiphene citrate increased total testosterone, LH and FSH over 16 weeks and maintained sperm concentration in the normal range, whereas testosterone gel did not maintain sperm counts.^[9] It remains a prescription-only matter for a doctor to decide; see our guide to enclomiphene vs clomid.

Evidence Quality at a Glance

Safety Concerns

How This Compares With Medical Treatment for Low Testosterone

For men with true testosterone deficiency, there are approved treatments. The Endocrine Society guideline recommends making the diagnosis only in men with symptoms and signs of deficiency plus unequivocally and consistently low morning testosterone concentrations, and recommends testosterone therapy for symptomatic men after discussing benefits and risks. It advises against starting therapy in several situations, including when a man is planning fertility in the near term.^[10] None of the peptides above is part of that guideline. For lifestyle approaches, see our TRT vs natural testosterone optimization guide and our testosterone supplements guide.

If You Are Curious About Peptides

We do not recommend self-administering peptides. If you are considering any of them, these are safer next steps:

The Bottom Line

Peptides are an active area of research, but the evidence for the ones marketed to men is thin, the regulatory picture is changing, and the risks of unapproved injectables are real. For most men, the better-supported foundations of hormonal health remain sleep, resistance training, balanced nutritionand a healthy body weight, along with a doctor's guidance when symptoms persist.